Happy Valley-based early-stage gene technology company NeuExcell Therapeutics is on the cusp of a life-changing breakthrough treatment for patients suffering from Huntington’s Disease, an incurable, hereditary brain disorder that affects different parts of the brain, impacting movement, behavior and cognition. In September, the company announced a gene therapy collaboration with Spark Therapeutics aimed at developing […]